<p>SkMC were transfected with siRNAs directed against MBNL1 and cell samples on each subsequent day post-siRNA transfection for a period of 5 days, were divided into 4 aliquots where one aliquot was used to measure MBNL1 levels and total RNA was extracted from each of the three other aliquots. Scrambled siRNA transfected samples were harvested on Day 5, the last time point of the experiment. <b>(A)</b> Total protein (10 µg) was analyzed by western blot to measure the silencing achieved for MBNL1 at 24 h intervals for 5 days. Blots were probed for GAPDH as an internal control. <b>(B)</b> Synthesized cDNAs were subjected to PCR analysis to study RNA splicing as indicated with <i>GAPDH</i> RNA as an internal control. In each case the levels of...
Muscleblind-like (MBNL) proteins are key regulators of precursor and mature mRNA metabolism in mam-m...
Current estimates indicate that approximately one-third of all disease-causing mutations are expecte...
Muscleblind-like 1 (MBNL1) regulates alternative splicing and is a key player in the disease mecha-n...
<p>Lower limb skeletal muscles from adult wild-type, <i>Mbnl1<sup>+/ΔE3</sup></i> and <i>Mbnl1<sup>Δ...
<p>RNA splice defects that manifest with the depletion of MBNL1 in SkMC and in <i>Mbnl1<sup>+/ΔE3</s...
<p>MCF-7 cells were transfected with SRSF1-6, Tra2β, SREK1, GAPDH (G) and Negative control (NC) siRN...
<p>RT PCR splicing assay results for inclusion/exclusion levels of respective exons upon over-expres...
The figure shows the tissue type and frequency where specific exons in Mbnl1 RNA mis-spliced upon FM...
Myotonic dystrophy (DM1) is a highly variable, multi-system disorder resulting from the expansion of...
(A) Changes in alternative RNA splicing across categories. (B) Violin plots illustrating the distrib...
(A, B) Gene structures of MBNL1 and MBNL2, adapted from [1,11]. Boxes represent exons, numbered 1–10...
<p>JAR cells were transfected with SRSF1-6, Tra2β, SREK1, GAPDH (G) and Negative control (NC) siRNAs...
For some neurological disorders, disease is primarily RNA mediated due to expression of non-coding m...
38 pages. A thesis presented to the Department of Chemistry and Biochemistry and the Clark Honors Co...
Alternative splicing factors regulate alternative exon repression or activation which allows one pre...
Muscleblind-like (MBNL) proteins are key regulators of precursor and mature mRNA metabolism in mam-m...
Current estimates indicate that approximately one-third of all disease-causing mutations are expecte...
Muscleblind-like 1 (MBNL1) regulates alternative splicing and is a key player in the disease mecha-n...
<p>Lower limb skeletal muscles from adult wild-type, <i>Mbnl1<sup>+/ΔE3</sup></i> and <i>Mbnl1<sup>Δ...
<p>RNA splice defects that manifest with the depletion of MBNL1 in SkMC and in <i>Mbnl1<sup>+/ΔE3</s...
<p>MCF-7 cells were transfected with SRSF1-6, Tra2β, SREK1, GAPDH (G) and Negative control (NC) siRN...
<p>RT PCR splicing assay results for inclusion/exclusion levels of respective exons upon over-expres...
The figure shows the tissue type and frequency where specific exons in Mbnl1 RNA mis-spliced upon FM...
Myotonic dystrophy (DM1) is a highly variable, multi-system disorder resulting from the expansion of...
(A) Changes in alternative RNA splicing across categories. (B) Violin plots illustrating the distrib...
(A, B) Gene structures of MBNL1 and MBNL2, adapted from [1,11]. Boxes represent exons, numbered 1–10...
<p>JAR cells were transfected with SRSF1-6, Tra2β, SREK1, GAPDH (G) and Negative control (NC) siRNAs...
For some neurological disorders, disease is primarily RNA mediated due to expression of non-coding m...
38 pages. A thesis presented to the Department of Chemistry and Biochemistry and the Clark Honors Co...
Alternative splicing factors regulate alternative exon repression or activation which allows one pre...
Muscleblind-like (MBNL) proteins are key regulators of precursor and mature mRNA metabolism in mam-m...
Current estimates indicate that approximately one-third of all disease-causing mutations are expecte...
Muscleblind-like 1 (MBNL1) regulates alternative splicing and is a key player in the disease mecha-n...